Exelixis Inc (EXEL)

Exchange
NASDAQ
Symbol
EXEL
Sector
Trade & Services
Industry
Services-commercial Physical & Biological Research
Description
Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development, and commercialization of new drugs to treat cancers in the United States. The company is headquartered in Alameda, California.
Country
USA

Stock price

At close: November 6, 2024

  • Open
    35.30
  • High
    35.84
  • Low
    34.97
  • Close
    35.51
  • Volume
    2,519,710

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
35.52
Receivables turnover
7.71
Payables turnover
18.22
Working capital turnover
1.98
Days of inventory on hand (DOH)
10.28
Days of sales outstanding (DSO)
47.35
Number of days of payables
20.03
Fixed asset turnover
14.22
Total asset turnover
0.62
 Liquidity ratios
Current ratio
3.34
Quick ratio
3.13
Cash ratio
2.52
Cash conversion cycle
37.59
 Solvency ratios
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
1.30
Interest coverage
6.50
 Profitability ratios
Gross profit margin
66.38%
Operating profit margin
9.34%
Pretax margin
14.07%
Net profit margin
11.35%
Operating return on assets (Operating ROA)
5.81%
Return on assets (ROA)
7.06%
Return on total capital
7.55%
Return on equity (ROE)
9.18%